Cargando…
The effect of a brief action planning intervention on adherence to double-blind study medication compared to a standard trial protocol in the Atorvastatin in Factorial with Omega EE90 Risk Reduction in Diabetes (AFORRD) clinical trial: a cluster randomised sub-study
AIMS: Clinical trial patients are highly motivated but may encounter difficulty in taking study medication regularly when treatment burden is substantial. We assessed a brief behavioural intervention, given in addition to a standard trial protocol. METHODS: We performed a two-arm adherence sub-study...
Autores principales: | Farmer, Andrew J., Oke, Jason, Hardeman, Wendy, Tucker, Lynne, Sutton, Stephen, Kinmonth, Ann-Louise, Griffin, Simon, Holman, Rury R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6078174/ https://www.ncbi.nlm.nih.gov/pubmed/27522034 http://dx.doi.org/10.1016/j.diabres.2016.07.004 |
Ejemplares similares
-
Economic Evaluation of Factorial Trials: Cost-Utility Analysis of the Atorvastatin in Factorial With Omega EE90 Risk Reduction in Diabetes 2 × 2 × 2 Factorial Trial of Atorvastatin, Omega-3 Fish Oil, and Action Planning
por: Dakin, Helen A., et al.
Publicado: (2020) -
The impact of individualised cardiovascular disease (CVD) risk estimates and lifestyle advice on physical activity in individuals at high risk of CVD: a pilot 2 × 2 factorial understanding risk trial
por: Price, Hermione C, et al.
Publicado: (2008) -
Protocol for SAMS (Support and Advice for Medication Study): A randomised controlled trial of an intervention to support patients with type 2 diabetes with adherence to medication
por: Farmer, Andrew J, et al.
Publicado: (2008) -
Does Electronic Monitoring Influence Adherence to Medication? Randomized Controlled Trial of Measurement Reactivity
por: Sutton, Stephen, et al.
Publicado: (2014) -
An explanatory randomised controlled trial of a nurse-led, consultation-based intervention to support patients with adherence to taking glucose lowering medication for type 2 diabetes
por: Farmer, Andrew, et al.
Publicado: (2012)